Mobocertinib
TAK-788-1003
Phase 1 small_molecule active
Quick answer
Mobocertinib for Non-Small Cell Lung Cancer is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Non-Small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active